BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1147579)

  • 1. Interactions of carbenicillin and ticarcillin with gentamicin.
    Davies M; Morgan JR; Anand C
    Antimicrob Agents Chemother; 1975 Apr; 7(4):431-4. PubMed ID: 1147579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo inactivation of gentamicin by carbenicillin and ticarcillin.
    Kradjan WA; Burger R
    Arch Intern Med; 1980 Dec; 140(12):1668-70. PubMed ID: 7458498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of gentamicin by penicillins in patients with renal failure.
    Ervin FR; Bullock WE; Nuttall CE
    Antimicrob Agents Chemother; 1976 Jun; 9(6):1004-11. PubMed ID: 938018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BL-P1654, ticarcillin, and carbenicillin: in vitro comparison alone and in combination with gentamicin against Pseudomonas aeruginosa.
    Wald ER; Standiford HC; Tatem BA; Calia FM; Hornick RB
    Antimicrob Agents Chemother; 1975 Mar; 7(3):336-40. PubMed ID: 806263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of carbenicillin, ticarcillin, sisomicin and netilmicin alone and in combination against Pseudomonas aeruginosa.
    Watanakunakorn C; Glotzbecker C
    Chemotherapy; 1978; 24(6):343-6. PubMed ID: 100282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparative synergistic activity of amikacin, gentamicin, netilmicin and azlocillin, mezlocillin, carbenicillin and ticarcillin against Serratia marcescens.
    Fu KP; Neu HC
    J Antibiot (Tokyo); 1978 Feb; 31(2):135-40. PubMed ID: 344298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gentamicin inactivation by piperacillin or carbenicillin in patients with end-stage renal disease.
    Thompson MI; Russo ME; Saxon BJ; Atkin-Thor E; Matsen JM
    Antimicrob Agents Chemother; 1982 Feb; 21(2):268-73. PubMed ID: 6462107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro activity and clinical pharmacology of ticarcillin and carbenicillin.
    Neu HC; Garvey GJ
    Antimicrob Agents Chemother; 1975 Oct; 8(4):457-62. PubMed ID: 1190752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of time and concentration upon interaction between gentamicin, tobramycin, Netilmicin, or amikacin and carbenicillin or ticarcillin.
    Pickering LK; Gearhart P
    Antimicrob Agents Chemother; 1979 Apr; 15(4):592-6. PubMed ID: 464591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gentamicin and ticarcillin in subjects with end-stage renal disease. Comparison of two assay methods and evaluation of inactivation rate.
    Russo ME; Atkin-Thor E
    Clin Nephrol; 1981 Apr; 15(4):175-80. PubMed ID: 7237864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of ticarcillin against anaerobic bacteria compared with that of carbenicillin and penicillin.
    Roy I; Bach V; Thadepalli H
    Antimicrob Agents Chemother; 1977 Feb; 11(2):258-61. PubMed ID: 848931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobramycin inactivation by carbenicillin, ticarcillin, and piperacillin.
    Konishi H; Goto M; Nakamoto Y; Yamamoto I; Yamashina H
    Antimicrob Agents Chemother; 1983 May; 23(5):653-7. PubMed ID: 6223576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of ticarcillin, carbenicillin and ampicillin against some gram-negative bacilli.
    Legakis NJ; Papavassiliou J
    J Antibiot (Tokyo); 1975 Nov; 28(11):912-9. PubMed ID: 811636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of concentration and time upon inactivation of tobramycin, gentamicin, netilmicin and amikacin by azlocillin, carbenicillin, mecillinam, mezlocillin and piperacillin.
    Pickering LK; Rutherford I
    J Pharmacol Exp Ther; 1981 May; 217(2):345-9. PubMed ID: 6453219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro evaluation of the effects of ticarcillin and carbenicillin upon Psuedomonas aeruginosa.
    Kalkani E; Marketos N
    Antimicrob Agents Chemother; 1976 Jan; 9(1):89-90. PubMed ID: 816248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro activity of tobramycin, gentamicin, kanamycin, colistin, carbenicillin, and ticarcillin and clinical isolates of Pseudomonas aeruginosa: epidemiological and therapeutic implications.
    Dulong de Rosnay HL; Grimont PA; Dessaut B; Lesgouarres MT
    J Infect Dis; 1976 Aug; 134 Suppl():S50-6. PubMed ID: 823279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of inoculum size on the activity of carboxy- and ureido-penicillins and effects of combinations of ureido-penicillins with aminoglycosides against resistant Pseudomonas aeruginosa.
    Watanakunakorn C
    J Antimicrob Chemother; 1986 Jan; 17(1):91-5. PubMed ID: 3081474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in-vitro activity of ticarcillin and carbenicillin against 100 clinical isolates of Pseudomonas aeruginosa.
    Pearman JW; Kosaras FP; Harper WE
    Med J Aust; 1978 Apr; 1(8):452-4. PubMed ID: 96319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antibacterial activity of four aminoglycosides and two semisynthetic penicillins on fresh clinical isolates from cancer patients.
    Moody MR; Young VM; Schimpff SC; Purvis DS; Wiernik PH
    Eur J Cancer (1965); 1979; 15 Suppl():23-33. PubMed ID: 261581
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of ticarcillin on gentamicin and tobramycin pharmacokinetics in a patient with end-stage renal disease.
    Matzke GR; Luckham DR; Collins AJ; Halstenson CE
    Pharmacotherapy; 1984; 4(3):158-60. PubMed ID: 6739313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.